Influenza Antiviral DAS181-F03

NCT01173224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: Placebo
DRUG: DAS181

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)